title: Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
abstract: OBJECTIVE
  Intermedin (IMD), a member of calcitonin family, was suggested to play a role in angiogenesis and cancer. The aim of this study was to investigate the role of IMD in the angiogenic process and the underlying mechanism, and the possibility for it to be used as a target for angiogenesis-based anticancer therapies.
  
  
  RESULTS
  Using in vivo and in vitro 3-dimensional angiogenic models, we found that IMD induced a well-ordered vasculature with hierarchical structure and had a synergistic effect with vascular endothelial growth factor. Using RNA interference, real-time polymerase chain reaction, and Western blot analysis, we found that IMD alleviated the undesirable effects of vascular endothelial growth factor by restricting the excessive vessel sprouting and uneven lumen formation through the regulation of vascular endothelial-cadherin and identified its receptor on the endothelial cells. Both mitogen-activated protein kinase/extracellular signal-regulated kinase and phosphoinositide 3-kinase/Akt activation were involved in the effects. Furthermore, using experimental tumor models, we demonstrated that IMD was involved in tumor angiogenesis, and the blockade of IMD severely impaired blood supply and eventually inhibited tumor growth.
  
  
  CONCLUSIONS
  We demonstrated that IMD played a critical role in the vascular remodeling process and tumor angiogenesis and may serve as a novel target for the development of angiogenesis-based anticancer therapies.
authors.affiliation: Molecular Medicine Research Center, West China Hospital, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Li-Jun
authors.initials: LJ
authors.lastname: Wang
authors.forename: Fei
authors.initials: F
authors.lastname: Xiao
authors.forename: Yi
authors.initials: Y
authors.lastname: Wei
authors.forename: Wei
authors.initials: W
authors.lastname: Ke
authors.forename: Hong-Bo
authors.initials: HB
authors.lastname: Xin
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism*; D001808:Blood Vessels / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D015153:Blotting, Western; D015820:Cadherins / Q000235:genetics / Q000378:metabolism*; D058286:Calcitonin Receptor-Like Protein / Q000378:metabolism; D045744:Cell Line, Tumor; D016922:Cellular Senescence; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D005347:Fibroblasts / Q000201:enzymology; D061307:Human Umbilical Vein Endothelial Cells / Q000201:enzymology; D006801:Humans; D020935:MAP Kinase Signaling System; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009131:Muscle, Smooth, Vascular / Q000201:enzymology; D032389:Myocytes, Smooth Muscle / Q000201:enzymology; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology; D009389:Neovascularization, Pathologic; D018919:Neovascularization, Physiologic; D036361:Peptide Hormones / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D058539:Phosphatidylinositol 3-Kinase / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D034622:RNA Interference; D060888:Real-Time Polymerase Chain Reaction; D058263:Receptor Activity-Modifying Protein 2 / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D014162:Transfection; D047368:Tumor Burden; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D000099152:Cadherin 5
chemical_list: D015703:Antigens, CD; D015820:Cadherins; D058286:Calcitonin Receptor-Like Protein; D048049:Extracellular Signal-Regulated MAP Kinases; D036361:Peptide Hormones; D058539:Phosphatidylinositol 3-Kinase; D051057:Proto-Oncogene Proteins c-akt; D058263:Receptor Activity-Modifying Protein 2; D042461:Vascular Endothelial Growth Factor A; D000099152:Cadherin 5; C484330:ADM2 protein, human; C545578:CALCRL protein, human; C545503:RAMP2 protein, human; C561869:intermedin (17-47)